Health TrialsbyHealthPanel

Prolonged Progesterone to Prevent Preterm Birth From IVF - ET

ConditionPreterm Birth
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age20-40
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

About this trial

To investigate the incidence of preterm birth in IVF fresh embryo transplantation cycle patients after prolonged vaginal progesterone treatment

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Progesterone Sustained-release vaginal gel

    Drug

    the treatment time of vaginal progesterone

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: The Trial groupExperimental treatment 1 intervention
Group B: The control groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of preterm birth

the symptom or diagnosis of preterm birth

Time frame
37 weeks of gestation

Secondary outcomes

1

live birth rate

Live birth is defined as the delivery of a neonate with heartbeat and breath at or beyond 28 gestational weeks. Live birth rate is calculated as the number of live births divided by the number of clinical pregnancies.

Time frame
The time frame is from the date of fresh embryo transfer until delivery, assessed up to 42 weeks of gestation plus 4 weeks post-delivery.
2

cervical length

The measurement is performed along the endocervical canal from the internal os to the external os.

Time frame
Cervical length is measured via ultrasound at 12, 16, 20, and 24 weeks of gestation.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Lead sponsor

Source ClinicalTrials.gov
Apply now